Jolanta Weglowska

Week Patients | Phase 3 Studies | Brodalumab Placebo | Plaque Psoriasis | Safety Ixekizumab

Prominent publications by Jolanta Weglowska

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

[ PUBLICATION ]

KOL Index score: 20967

BACKGROUND: Early clinical studies suggested that the anti-interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis.

METHODS: In two phase 3 studies (AMAGINE-2 and AMAGINE-3), patients with moderate-to-severe psoriasis were randomly assigned to receive brodalumab (210 mg or 140 mg every 2 weeks), ustekinumab (45 mg for patients with a body weight ≤100 kg and 90 mg for patients >100 kg), or placebo. At week 12, patients receiving brodalumab were ...

Also Ranks for: Brodalumab Patients | placebo week | phase 3 studies | ustekinumab psoriasis | monoclonal antibodies

Key People For Week Patients

Top KOLs in the world

Paul *****

rheumatoid arthritis ankylosing spondylitis radiographic progression

Josef ********* ******

rheumatoid arthritis systemic lupus erythematosus radiographic progression

Désirée * * * *** *** ******

rheumatoid arthritis ankylosing spondylitis radiographic progression

Maxime * ********

rheumatoid arthritis ankylosing spondylitis desir cohort

Arthur * *********

psoriatic arthritis celgene corporation week patients

Philip * *****

psoriatic arthritis eli lilly novartis pfizer

Select a search phrase week patients , week patients uc , week patients qol , week patients life , week patients age

Jolanta Weglowska:Expert Impact

Concepts for whichJolanta Weglowskahas direct influence:Week patients, Brodalumab patients, Patients brodalumab, Phase 3 studies, Placebo week, Brodalumab placebo, Plaque psoriasis, Placebo brodalumab.

Jolanta Weglowska:KOL impact

Concepts related to the work of other authors for whichfor which Jolanta Weglowska has influence:Plaque psoriasis, Psoriatic arthritis, Monoclonal antibodies, Brodalumab patients, Th17 cells, Biologic agents, Atopic dermatitis.

Tools

Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile https://www.keyopinionleaders.com/Week-Patients/Jolanta-Weglowska-For-The-IxoraPeds-Investigators--Niepu-d32c7387d011daf3b777d3ab41930056-zb.html

for the IXORA-PEDS Investigators | Niepubliczny Zakład Opieki Zdrowotnej multiMedica, Wrocław (J.W.), and Lubelskie Centrum Diagnostyczne, Świdnik (T.B.) — both in Poland